Paris, France

XiaoFei Wang

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Commissariat a L'energie Atomique Et Aux Energies Alternatives. Active years: 2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: XiaoFei Wang. Retrieved from https://idiyas.com/inventor/xiaofei-wang-7ge5b30y

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile



Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2017

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of XiaoFei Wang in Immunology

Introduction

XiaoFei Wang is a prominent inventor based in Paris, France. He has made significant contributions to the field of immunology, particularly through his innovative research and patents. His work focuses on the development of vaccines and diagnostic tools that leverage the immune system's capabilities.

Latest Patents

XiaoFei Wang holds a patent for "CD4+ T survivin epitopes and uses thereof." This invention concerns CD4+ T survivin epitopes and their applications in vaccines and diagnostics. His patent represents a crucial advancement in the understanding and treatment of various diseases.

Career Highlights

Wang is affiliated with the Commissariat à l'Énergie Atomique et aux Énergies Alternatives, a leading research institution in France. His role at this organization allows him to collaborate with other experts in the field and contribute to groundbreaking research.

Collaborations

Throughout his career, XiaoFei Wang has worked alongside notable colleagues such as Gaetan Munier and Bernard Maillere. These collaborations have further enhanced his research and the impact of his inventions.

Conclusion

XiaoFei Wang's innovative work in immunology, particularly his patent on CD4+ T survivin epitopes, showcases his dedication to advancing medical science. His contributions are vital for the development of new vaccines and diagnostic methods, highlighting the importance of his research in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…